126456-43-7, Catalysts function by providing an alternate reaction mechanism that has a lower activation energy than would be found in the absence of the catalyst. In a patent, 126456-43-7, molecular formula is C9H11NO, introducing its new discovery.
ANTIVIRAL PROTEASE INHIBITORS
Compounds of the formula (I) wherein: X and Y are hydroxy or H. A’ and A” are terminal amine functions such valinamide or indanolamine. Z’ and Z” along with the adjacent ()n groups are independently alkylaryl have utility as HIV aspartyl protease inhibitors with particularly good activity in the presence of human serum.
Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.126456-43-7, you can also check out more blogs about126456-43-7
Reference£º
Chiral nitrogen ligands in late transition metal-catalysed asymmetric synthesis¡ªI. Addressing the problem of ligand lability in rhodium-catalysed hydrosilations,
Nitrogen-Containing Ligands for Asymmetric Homogeneous and Heterogeneous Catalysis